EHC Company Profile and Key Details

Q: Who are the executives of EHC?

Mr. Andrew L. PriceSenior Vice President & Chief Accounting OfficerMr. John Patrick DarbyExecutive Vice President, Gen. Counsel & Corporation Sec.Mr. Rusty YeagerChief Information Officer & Senior Vice PresidentMr. Anthony A. HernandezChief HR OfficerMs. Elissa Joy CharbonneauChief Medical OfficerMr. Mark J. TarrChief Executive Officer, Pres & DirectorMr. Frank BrownPres of Southwest RegionMr. Douglas E. ColtharpExecutive Vice President & Chief Financial OfficerMs. Dawn RockChief Compliance OfficerDr. Elissa Joy Charbonneau D.O., M.S.Chief Medical Officer

NYSE : EHC

Encompass Health

$104.86

-1.135-1.07%

Open: 2:53 PM

69.39

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Encompass Health Corporation (EHC) stock declined over -1.07%, trading at $104.86 on NYSE, down from the previous close of $105.99. The stock opened at $104.40, fluctuating between $101.68 and $105.49 in the recent session.

Stock Snapshot

105.99

Prev. Close

10.4B

Market Cap

101.675

Day Low

17.95

P/E Ratio

5.84

EPS (TTM)

-0.04

Cash Flow per Share

104.4

Open

99.2M

Number of Shares

105.49

Day High

98.51%

Free Float in %

23.67

Book Value

339.77K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 20, 2026	104.97	106.86	103.99	105.99	641.83K
May 19, 2026	106.31	106.34	101.89	104.76	695.78K
May 18, 2026	106.75	108.31	105.63	106.10	1.1M
May 15, 2026	108.34	108.34	106.32	106.64	708.78K
May 14, 2026	107.77	109.00	106.81	107.30	927.89K
May 13, 2026	107.56	109.89	107.21	107.49	738.76K
May 12, 2026	105.44	109.75	104.28	108.08	1.06M
May 11, 2026	106.14	106.80	103.77	104.82	554.32K
May 08, 2026	107.70	108.64	105.87	106.10	786.57K
May 07, 2026	105.08	107.59	105.05	107.15	1.31M
May 06, 2026	105.92	107.90	105.00	105.01	1.03M
May 05, 2026	106.48	106.68	103.40	105.16	813.32K
May 04, 2026	106.73	109.26	106.43	106.64	1.2M
Apr 30, 2026	101.93	102.84	98.28	100.00	2.1M
Apr 29, 2026	100.91	102.86	100.90	102.61	1.38M
Apr 28, 2026	101.94	103.00	100.91	101.69	916.23K
Apr 27, 2026	101.57	103.19	100.77	100.92	619.52K
Apr 23, 2026	102.46	102.71	101.06	101.86	669.99K
Apr 22, 2026	103.38	104.62	102.02	102.17	862.29K
Apr 21, 2026	106.58	107.15	102.74	102.77	761K

Contact Details

Birmingham, AL 35242

United States

https://www.encompasshealth.com 205 967 7116

About Company

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.

Stock Peers

CHE

1.56+0.35%

Chemed Corporation$441.61 HCA

-8.02-1.98%

HCA Healthcare, Inc.$396.67 DVA

2.26+1.16%

DaVita Inc.$196.87 THC

-3.99-2.08%

Tenet Healthcare Corporation$187.41 UHS

-2.13-1.28%

Universal Health Services, Inc.$164.32 AGL

-7.26-8.23%

Agilon Health, Inc.$80.94 BKDT

-2.09-2.62%

Brookdale Senior Living Inc. 7.$77.60 SOLV

1.4+1.87%

Solventum Corporation$76.13 USPH

0.63+1.02%

U.S. Physical Therapy, Inc.$62.24 SNDA

0.43+1.19%

Sonida Senior Living, Inc.$36.63

Company Overview

Encompass Health Corporation (NYSE:EHC) closed at $104.86 USD, losing -$1.13 (-1.07%) from the previous close of $105.99. The stock is currently mid-range between its 52-week high and low $92.77 and $127.99. With a market capitalization of about $10.40 billion, Encompass Health Corporation is classified as a large-cap and shows lower-than-market volatility (beta ~0.58). Key stats such as the average daily volume over the past year has been around 968.52 thousand shares, volume is running light vs its 52-week average. Headquartered in Birmingham, AL, Encompass Health Corporation operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Mark J. Tarr, the company employs approximately 28,572 people and listed since September 24, 1986. Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 2.81%, SMA50 3.06%, SMA200 -6.94%). The stock’s 14-day RSI is 55.83 (neutral), while the ATR of 3.32 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -16.24% below its high and over 15.85% above its low. Average 10-day trading volume of 803.72 thousand shares is below the 3-month average of 942.09 thousand, indicating normal recent market interest.

Valuation Metrics

Encompass Health Corporation trades at a P/E ratio of 17.18, slightly below the S&P 500 average, with a price-to-sales ratio of 1.73 and a price-to-book ratio of 4.15 trading at moderately above to book value. The P/FCF stands at 22.54, also below market averages.

Dividend & Fair Value

Encompass Health Corporation last paid a dividend of 0.76 per share, this equals a trailing yield of roughly 0.62%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $115.25. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Encompass Health Corporation generated EPS of $5.54 over the past year. Five-year average earnings growth is 14.24%. Wall Street analysts project EPS growth of 8.9% annually over the next five years. The latest quarter delivered EPS of $1.80. The next quarter is forecast at $1.50. Next year's EPS is expected at $9.35. Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $160.00 to $140.00. The high target offers 50.96% upside. The low target suggests 32.09% downside. The mean target is $146.62. This offers 38.33% upside. Encompass Health Corporation earnings surprise history is a consistent trend of beating forecasts. The quarter that ended April 30, 2026, missed forecasts by 19.21%. The prior quarter beat by 13.18%. Over the last six quarters, Apple has recorded several small beats. These include 11.43% in February 06, 2025.

Shareholding & Insider Activity

Encompass Health Corporation has 100.72 million shares outstanding. The public float is 99.22 million shares, elevated short interest at 1.15% of float. This equals 1.03 million shares. The short ratio is 0.94 days. Institutional investors hold 97.5% of the float. Insiders own 1.41%. GRINNEY JAY holds 1.12 million shares, Tarr Mark J has 377.07 thousand shares and Workman John L has 91.80 thousand shares. Over the past six months, insider transactions show net selling. They sold 15.64 thousand shares across 4 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Encompass Health generated $4.80B in revenue, or $47.40 per share. Gross margin was 19.44%, operating margin 15.24%, and net profit margin 7.33%. Returns are healthy, with ROA at 5.77% and ROE at 21.37%.
On valuation metrics, Encompass Health trades at a P/E of 17.18, P/S of 1.73 and P/B of 4.15. The current ratio is 1.17 and quick ratio is 1.17. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 10.87 days. Debt-to-equity is 1.11, supported by a cash flow-to-debt ratio of 0.43.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Encompass Health posted revenue of $4.80B, down slightly from $4.35B in the prior quarter. Gross profit was $933.50M (margin 19.44%). Operating income was $731.80M (margin 15.2%). Net income was$352.00M (EPS $3.51).
The company ended the quarter with $141.80M in cash and short-term investments, a total debt of $2.93B, and net debt of $2.83B. Total assets were $6.10B, with equity of $2.30B. Financials further reflected stability, with operating cash flow of $850.80M, free cash flow of $267.70M, and capital expenditures of - $583.10M.

Price Forecast & Outlook

Our AI price prediction model suggests that Encompass Health Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.5%, with price expected at $108.64 by June 03, 2026, within a range of $105.71 to $111.74 3-Month Outlook: Projected fall of -8.79%, reaching $96.67 by August 18, 2026, with a range of $92.78 to $100.21. 1-Year Outlook: Projected gain of 22.29%, with price at $129.62 by May 20, 2027, within a range of $126.53 to $133.01.

Key Takeaways

Encompass Health Corporation (NYSE:EHC) shares are flat -6.89% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Encompass Health Corporation trading at a premium to the broader market with a P/E of 17.18. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $97.10, suggesting -8.39% downside. Our AI forecast model points to short-term strength (2.5% over two weeks), a medium-term fall (-8.79% over three months), and a longer-term gain (22.29% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Encompass Health Corporation (EHC) stock price?

Encompass Health Corporation (NYSE: EHC) stock price is $104.86 in the last trading session. During the trading session, EHC stock reached the peak price of $105.49 while $101.68 was the lowest point it dropped to. The percentage change in EHC stock occurred in the recent session was -1.07% while the dollar amount for the price change in EHC stock was - $1.14.

EHC's industry and sector of operation?

The NYSE listed EHC is part of Medical - Care Facilities industry that operates in the broader Healthcare sector. Encompass Health Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of EHC?

Mr. Andrew L. Price
Senior Vice President & Chief Accounting Officer
Mr. John Patrick Darby
Executive Vice President, Gen. Counsel & Corporation Sec.
Mr. Rusty Yeager
Chief Information Officer & Senior Vice President
Mr. Anthony A. Hernandez
Chief HR Officer
Ms. Elissa Joy Charbonneau
Chief Medical Officer
Mr. Mark J. Tarr
Chief Executive Officer, Pres & Director
Mr. Frank Brown
Pres of Southwest Region
Mr. Douglas E. Coltharp
Executive Vice President & Chief Financial Officer
Ms. Dawn Rock
Chief Compliance Officer
Dr. Elissa Joy Charbonneau D.O., M.S.
Chief Medical Officer

How EHC did perform over past 52-week?

EHC's closing price is 14.25% higher than its 52-week low of $92.77 where as its distance from 52-week high of $127.99 is -17.19%.

How many employees does EHC have?

Number of EHC employees currently stands at 28,572.

Link for EHC official website?

Official Website of EHC is: https://www.encompasshealth.com

How do I contact EHC?

EHC could be contacted at phone 205 967 7116 and can also be accessed through its website. EHC operates from 9001 Liberty Parkway, Birmingham, AL 35242, United States.

How many shares of EHC are traded daily?

EHC stock volume for the day was 339.77K shares. The average number of EHC shares traded daily for last 3 months was 968.52K.

What is the market cap of EHC currently?

The market value of EHC currently stands at $10.40B with its latest stock price at $104.86 and 99.2M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	28572
Beta	0.56
Sales or Revenue	$4.80B
5Y Sales Change%	0.104%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Care Facilities

EHC Company Profile and Key Details

Encompass Health

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Earnings & Analyst Outlook

Company Overview

Shareholding & Insider Activity

Valuation Metrics

Financial & Profitability Overview

Quarterly Financial Highlights

Key Takeaways

Price Forecast & Outlook